血压与新冠病毒疾病严重程度之间的关联。 - Suppr

Suppr

超能文献

Association between blood pressure and COVID-19 severity.

作者信息

Yoshihara Fumiki

机构信息

National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

出版信息

Hypertens Res. 2024 Mar;47(3):683-684. doi: 10.1038/s41440-023-01557-8. Epub 2023 Dec 25.

DOI:10.1038/s41440-023-01557-8

PMID:38145992

Abstract

摘要

相似文献

Association between blood pressure and COVID-19 severity.血压与新冠病毒疾病严重程度之间的关联。

Hypertens Res. 2024 Mar;47(3):683-684. doi: 10.1038/s41440-023-01557-8. Epub 2023 Dec 25.

Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force.日本 2019 年冠状病毒病患者的高血压病史和入院时血压的预后意义：来自日本 COVID-19 工作组的综合分析。

Hypertens Res. 2024 Mar;47(3):639-648. doi: 10.1038/s41440-023-01490-w. Epub 2023 Nov 2.

Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan.2019 年冠状病毒病首次宣布进入紧急状态导致的压力对日本门诊血压管理的影响。

Hypertens Res. 2022 Apr;45(4):675-685. doi: 10.1038/s41440-021-00832-w. Epub 2021 Dec 24.

Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19.高血压与炎症状态的相互作用及其对 COVID-19 患者血压和结局的影响。

J Clin Hypertens (Greenwich). 2021 Feb;23(2):238-244. doi: 10.1111/jch.14137. Epub 2021 Jan 24.

Direct Comparison of Home Versus Ambulatory Defined Nocturnal Hypertension for Predicting Cardiovascular Events: The Japan Morning Surge-Home Blood Pressure (J-HOP) Study.家庭血压与动态血压夜间血压对预测心血管事件的直接比较：日本清晨血压-家庭血压（J-HOP）研究。

Hypertension. 2020 Aug;76(2):554-561. doi: 10.1161/HYPERTENSIONAHA.119.14344. Epub 2020 Jun 15.

Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy.抗高血压药物治疗会影响 COVID-19 感染的高血压患者的临床预后吗？来自意大利南部中心的数据。

J Am Heart Assoc. 2020 Sep;9(17):e016948. doi: 10.1161/JAHA.120.016948. Epub 2020 Jul 7.

Will obesity break your heart - cardiac biomarkers in the Japan Morning Surge-Home Blood Pressure study.肥胖会伤“心”——日本晨间血压研究中心脏生物标志物分析。

Hypertens Res. 2024 Mar;47(3):808-810. doi: 10.1038/s41440-023-01560-z. Epub 2024 Jan 10.

Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection.血压调节异常在 COVID-19 中的肾脏和死亡率结局中的作用。在 SARS-CoV-2 感染中肾脏、血压和死亡率。

J Nephrol. 2021 Apr;34(2):305-314. doi: 10.1007/s40620-021-00997-0. Epub 2021 Mar 3.

Reynolds risk score as a risk assessment tool for cardiovascular disease after 10 years: its strong relationship with blood pressure.雷诺兹风险评分作为10年后心血管疾病的风险评估工具：它与血压的密切关系。

J Clin Hypertens (Greenwich). 2012 Aug;14(8):571-2. doi: 10.1111/j.1751-7176.2012.00644.x. Epub 2012 May 3.

Day-to-day blood pressure variability in COVID-19: A biomarker of disrupted central autonomic network.新型冠状病毒肺炎患者的日常血压变异性：中枢自主神经网络紊乱的生物标志物

J Clin Hypertens (Greenwich). 2022 Mar;24(3):234-236. doi: 10.1111/jch.14438. Epub 2022 Feb 7.

引用本文的文献

Prevalence of comorbidities and their association with disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis.COVID-19患者合并症的患病率及其与疾病严重程度和死亡率的关联：一项系统综述和荟萃分析。

J Multimorb Comorb. 2025 Aug 28;15:26335565251371256. doi: 10.1177/26335565251371256. eCollection 2025 Jan-Dec.

本文引用的文献

Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.肾素-血管紧张素系统通路治疗与 COVID-19 住院男性患者的改善结局相关。

Crit Care Med. 2022 Sep 1;50(9):1306-1317. doi: 10.1097/CCM.0000000000005589. Epub 2022 May 18.

Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.65 岁及以上成年人在 SARS-CoV-2 感染后急性后期持续出现和新发临床后遗症的风险：回顾性队列研究。

BMJ. 2022 Feb 9;376:e068414. doi: 10.1136/bmj-2021-068414.

Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic.新冠疫情期间美国成年人血压升高情况被观察到。

Circulation. 2022 Jan 18;145(3):235-237. doi: 10.1161/CIRCULATIONAHA.121.057075. Epub 2021 Dec 6.

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial.替米沙坦治疗新冠肺炎患者：一项开放的多中心随机临床试验。

EClinicalMedicine. 2021 Jun 18;37:100962. doi: 10.1016/j.eclinm.2021.100962. eCollection 2021 Jul.

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.SARS-CoV-2 感染急性期后临床后遗症风险：回顾性队列研究。

BMJ. 2021 May 19;373:n1098. doi: 10.1136/bmj.n1098.

Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic.使用血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂的2019冠状病毒病患者的死亡率、严重程度及住院情况：一项基于对第一波疫情反应对国家进行分层的荟萃分析

Healthcare (Basel). 2021 Jan 28;9(2):127. doi: 10.3390/healthcare9020127.

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.高血压与 COVID-19 时代的相关疾病：日本高血压学会 COVID-19 工作组报告。

Hypertens Res. 2020 Oct;43(10):1028-1046. doi: 10.1038/s41440-020-0515-0. Epub 2020 Jul 31.

Risk Factors for Mortality in Patients with COVID-19 in New York City.纽约市 COVID-19 患者死亡的风险因素。

J Gen Intern Med. 2021 Jan;36(1):17-26. doi: 10.1007/s11606-020-05983-z. Epub 2020 Jun 30.

Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.SARS-CoV-2 受体 ACE2 基因表达和调控的个体差异。

Aging Cell. 2020 Jul;19(7). doi: 10.1111/acel.13168. Epub 2020 Jun 19.

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。

Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验